Significance of cerebral microinfarcts in antiphospholipid syndrome: A population-based study

被引:2
作者
Naftali, Jonathan [1 ,2 ]
Barnea, Rani [1 ,2 ]
Eliahou, Ruth [2 ,3 ]
Saliba, Walid [4 ,5 ]
Bloch, Sivan [5 ,6 ]
Findler, Michael [1 ,2 ]
Brauner, Ran [1 ,2 ]
Shochat, Tzippy [7 ]
Leader, Avi [8 ]
Auriel, Eitan [1 ,2 ]
机构
[1] Rabin Med Ctr, Dept Neurol, Zeev Jabotinsky St 39, Petah Tiqwa 49100, Israel
[2] Tel Aviv Univ, Fac Med, Tel Aviv, Israel
[3] Rabin Med Ctr, Dept Radiol, Petah Tiqwa, Israel
[4] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel
[5] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
[6] Lady Davis Carmel Med Ctr, Dept Neurol, Haifa, Israel
[7] Rabin Med Ctr, Petah Tiqwa, Israel
[8] Mem Sloan Kettering Canc Ctr, Dept Med, Hematol Serv, New York, NY USA
关键词
Acute ischemic stroke; antiphospholipid syndrome; MRI; DWI lesions; cerebral microinfarcts; lesions; ANTIBODIES; BIOMARKERS;
D O I
10.1177/17474930241293236
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Acute ischemic stroke (AIS) or transient ischemic attack (TIA) is the most common neurological manifestations of patients with antiphospholipid syndrome (APS). Incidental diffusion-weighted imaging (DWI) positive subcortical and cortical lesions, or acute incidental cerebral microinfarcts (CMI), are microscopic ischemic lesions, detectable on MRI for 10-14 days only. We aimed to look at the prevalence of acute incidental CMI in a cohort of patients with APS and their association with subsequent AIS or TIA. Methods: This is a population-based cohort study of adults with APS diagnosis using International Statistical Classification-9 (ICD-9) and supporting laboratory results between January 2014 and April 2020. We included any patient undergoing brain MRI (index event) during the year prior APS diagnosis or at any time point following diagnosis. Age-matched subjects with negative APS laboratory workup were used as a control group. In the first analysis, we compared acute incidental CMI prevalence in both groups. We then performed a second analysis among APS patients only, comparing patients with and without acute incidental CMI for AIS or TIA as the primary outcome. Cox proportional hazards models used to calculate hazards ratio (HR) and 4 years cumulative risk. Results: 292 patients were included, of which, 207 patients with APS. Thirteen patients with APS had acute incidental CMI on MRI (6.3%), compared with none in the control group (p = 0.013). Following multivariable analysis, APS was the sole factor associated with acute incidental CMI (p = 0.026). During a median follow-up of 4 years (IQR 3.5, 4) in patients with APS, following multivariable analysis, acute incidental CMI was associated with subsequent AIS or TIA (HR 6.73 [(95% CI, 1.96-23.11], p < 0.01). Conclusion: Acute incidental CMI are more common among patients with APS than in patients with negative APS tests, and are associated with subsequent AIS or TIA. Detecting acute incidental CMI in patients with APS may guide etiological workup and reevaluation of antithrombotic regimen.
引用
收藏
页码:186 / 195
页数:10
相关论文
共 50 条
  • [21] A population-based study of neuromyelitis optica in Caucasians
    Asgari, N.
    Lillevang, S. T.
    Skejoe, H. P. B.
    Falah, M.
    Stenager, E.
    Kyvik, K. O.
    NEUROLOGY, 2011, 76 (18) : 1589 - 1595
  • [22] Recurrent reversible cerebral vasoconstriction syndrome and antiphospholipid syndrome
    Arlos Sowanou
    Aurelian Ungureanu
    Claire Aguesse
    Acta Neurologica Belgica, 2024, 124 : 329 - 334
  • [23] Significance of Laboratory and Clinical Manifestations of Antiphospholipid Syndrome
    王兆钺
    血栓与止血学, 2010, 16 (01) : 3 - 4
  • [24] Epidemiology of Antiphospholipid Syndrome in the General Population
    Dabit, Jesse Y.
    Valenzuela-Almada, Maria O.
    Vallejo-Ramos, Sebastian
    Duarte-Garcia, Ali
    CURRENT RHEUMATOLOGY REPORTS, 2021, 23 (12)
  • [25] The prevalence and incidence of thrombotic primary antiphospholipid syndrome in adults aged 18-49 years: A population-based study in a mountain community in northern Italy
    Andreoli, Laura
    Nalli, Cecilia
    Raffetti, Elena
    Angeli, Fabrizio
    Pascariello, Greta
    Zentilin, Arianna
    Pedersoli, Federica
    Gasparotti, Cinzia
    Magoni, Michele
    Scarcella, Carmelo
    Martini, Giuliana
    Franceschini, Franco
    Donato, Francesco
    Tincani, Angela
    CLINICAL IMMUNOLOGY, 2024, 260
  • [26] THROMBOTIC CEREBRAL ARTERIOPATHY IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME
    HUGHSON, MD
    MCCARTY, GA
    SHOLER, CM
    BRUMBACK, RA
    MODERN PATHOLOGY, 1993, 6 (06) : 644 - 653
  • [27] Epidemiology of Antiphospholipid Syndrome in the General Population
    Jesse Y. Dabit
    Maria O. Valenzuela-Almada
    Sebastian Vallejo-Ramos
    Alí Duarte-García
    Current Rheumatology Reports, 2021, 23
  • [28] Cardiac and cerebral manifestations in patients with antiphospholipid syndrome
    Jung, F
    Miesbach, W
    Scharrer, I
    ZEITSCHRIFT FUR KARDIOLOGIE, 2002, 91 (08): : 650 - 658
  • [29] Isolated Cerebral Sinovenous Thrombosis: A Rare Case of Neonatal Antiphospholipid Syndrome
    Pia, De Carolis Maria
    Silvia, Salvi
    Iliana, Bersani
    Sara, De Carolis
    INDIAN PEDIATRICS, 2012, 49 (05) : 411 - 412
  • [30] Serum immunoglobulins and biomarkers of dementia: a population-based study
    Yaqub, Amber
    Khan, Samer R.
    Vernooij, Meike W.
    van Hagen, P. Martin
    Peeters, Robin P.
    Ikram, M. Arfan
    Chaker, Layal
    Dalm, Virgil A. S. H.
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)